The immune system of mucosal tissues must effectively protect the host from pathogen invasion, while facilitating homeostatic interactions with a diverse colonizing microbiota. A clear understanding of the key molecules and mechanisms that achieve this delicate balance remains incomplete, leaving a gap in critical knowledge. This investigation, AI32438, has focused on D-defensins HD5 (DEFA5) and HD6 (DEFA6) as key effector molecules of innate immunity. These D-defensins are the most abundant antimicrobial peptides of human Paneth cells and compelling evidence shows that dysrupted Paneth cell function increases susceptibility to enteric pathogens, as well as to chronic inflammatory bowel disease. Published studies previously funded by this grant have established significant knowledge about the structure, microbicidal activities, and biological functions of HD5. In contrast, comparatively little is known about its Paneth cell partner, HD6 - an abundant D-defensin that is exceptionally well-conserved among primates. We discovered that HD6 has a novel mechanism of protective action. Unlike HD5 and other defensin peptides that protect the host through microbicidal activity, HD6 does not kill microbes but rather protects the intestinal mucosa by blocking microbial invasion. Our recently published data support a mechanism that involves trypsin- mediated processing of inactive stored proHD6 that generates a mature peptide capable of binding to surface proteins of microbes, followed by self-assembly of additional HD6 peptide molecules to form microbe-entangling nanofibrils and nanonets, which prevent penetration into host cells. The objectives for this proposal are to define the molecular details of this process, including pinpointing the target on microbial surface proteins that initiates initial binding of HD6 peptides, elucidating the structural features of HD6 that promote self-assembly, determining how HD6 impairs fagellar-driven microbial propulsion to mediate protection, and illuimate the consequences of HD6 binding to microbial antigens in shaping mucosal immune respones. We propose a combination of complementary approaches to accomplish these goals. By determining the fundamental features of HD6 function, these experiments will characterize a novel mechanism of protection and mucosal homeostasis afforded by the innate immune system. Successful completion of these studies will have broad impact on our mechanistic understanding of mucosal innate immunity will fill a void in knowledge on a conserved, highly abundant human defensin, as identification of the target for HD6 binding may reveal a new pathogen-associated molecular pattern (PAMP), and the structure-function analyses of HD6 will yield fundamental knowledge on mechanisms of peptide self-assembly.

Public Health Relevance

Defensins are fundamental immune molecules found throughout nature that both provide critical host defense from pathogenic microbes and contributions to homeostasis at mucosal surfaces of the body. Relatively little is known about human defensin 6 (HD6, DEFA6), a highly expressed D-defensin that is released into the lumen of the small intestine by specialized secretory (Paneth) cells. By elucidating the mechanism by which HD6 functions, these studies will provide a frame work for how certain D-defensins can bind microbial antigens and self-assemble into protective macromolecular complexes. The goals should yield insight into why Paneth cell dysfunction is associated with susceptibility to chronic inflammatory disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
4R37AI032738-21
Application #
9799168
Study Section
Special Emphasis Panel (NSS)
Program Officer
Rothermel, Annette L
Project Start
1993-07-01
Project End
2023-01-31
Budget Start
2020-02-01
Budget End
2021-01-31
Support Year
21
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California Davis
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Xu, Dan; Liao, Chongbing; Zhang, Bing et al. (2018) Human Enteric ?-Defensin 5 Promotes Shigella Infection by Enhancing Bacterial Adhesion and Invasion. Immunity 48:1233-1244.e6
Nguyen, Trang T T; Kläsener, Kathrin; Zürn, Christa et al. (2017) The IgM receptor Fc?R limits tonic BCR signaling by regulating expression of the IgM BCR. Nat Immunol 18:321-333
Chang, Cindy; Lleo, Ana; Kananurak, Anchasa et al. (2017) Human ?-Defensin 2 in Primary Sclerosing Cholangitis. Clin Transl Gastroenterol 8:e80
Bergman, P; Roan, N R; Römling, U et al. (2016) Amyloid formation: functional friend or fearful foe? J Intern Med 280:139-52
Ottolini, Barbara; Hornsby, Michael J; Abujaber, Razan et al. (2014) Evidence of convergent evolution in humans and macaques supports an adaptive role for copy number variation of the ?-defensin-2 gene. Genome Biol Evol 6:3025-38
Underwood, Mark A; Arriola, Jennifer; Gerber, Colin W et al. (2014) Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota. Pediatr Res 76:326-33
Jones, Eric A; Kananurak, Anchasa; Bevins, Charles L et al. (2014) Copy number variation of the beta defensin gene cluster on chromosome 8p influences the bacterial microbiota within the nasopharynx of otitis-prone children. PLoS One 9:e98269
McSorley, Stephen J; Bevins, Charles L (2013) Paneth cells: targets of friendly fire. Nat Immunol 14:114-6
Bevins, Charles L (2013) Innate immune functions of ?-defensins in the small intestine. Dig Dis 31:299-304
Rivera-Chávez, Fabian; Winter, Sebastian E; Lopez, Christopher A et al. (2013) Salmonella uses energy taxis to benefit from intestinal inflammation. PLoS Pathog 9:e1003267

Showing the most recent 10 out of 38 publications